Document is current
Any future updates will be listed below
-
Authors
Lee, Minyoung
Lee, Hokyou
Kim, Eun-Jin
Son, Dasom
Lee, Hyeok-Hee
Kim, Hyeon Chang
Kang, Eun Seok
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (NRF‒2021R1I1A1A01048435)
Ministry of Science and ICT, South Korea (2022R1F1A1066181)
Ministry of Science and ICT, South Korea (RS-2023-00209104)
Korea Medical Institute
Daewoong Pharmaceutical Company
Korea Health Industry Development Institute (RS-2023-KH136889)
- License Information
-
More Information
Article History
Received: 11 June 2024
Accepted: 8 April 2026
First Online: 12 May 2026
Declarations
:
: The study protocol was approved by the Institutional Review Board of Yonsei University Health System, Seoul, Korea (Y-2019-0084, 4-2022-0121, 4-2023-0336). Informed consent was waived, as this was a retrospective study of anonymized, routinely collected data.
: Not applicable.
: M.L. has received lecture honoraria from JW Pharmaceutical Corporation, Boryung Corporation, Eli Lilly and Company, Merck Sharp & Dohme, HK inno.N, Servier Korea, Handok Inc., Daewoong Pharmaceutical, KUKJE PHARM CO.,LTD, and GC Biopharma Corporation. All other authors have no conflicts to disclose; no other relationships or activities that could appear to have influenced the submitted work.
